Speaker illustration

Professor Gianluigi Savarese

Karolinska Institute, Stockholm (Sweden)

Member of:

European Society of Cardiology
Heart Failure Association

Gianluigi Savarese is an Italian/Swedish cardiologist, currently Associate Professor of Cardiology and Senior Lecturer at Karolinska Institutet, and Heart Failure Specialist at the Karolinska University Hospital, Stockholm, Sweden. Over the last few years, he has published ~300 articles on top peer reviewed journals. Major focus of his research is heart failure, with a particular interest in implementing use of guidelines recommended treatments, and phenotyping heart failure for improving clinical trial design. He is heavily involved in registry studies (Swedish Heart Failure Registry, ESC registries) and clinical trials, and he is expert in meta-analysis and big data analysis. He is board member of the Heart Failure Association and of the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology. Among others, he is Deputy Editor of EHJ-Open, EHJ-CR, and Associate Editor of European Journal of Heart Failure.

Industry perspective in heart failure clinical trials

Event: HFA Clinical Trials in Heart Failure Course

Topic: Heart Failure

Session type: Industry Session

Thumbnail

Farewell

Event: HFA Clinical Trials in Heart Failure Course

Topic: Heart Failure

Session type: Special Event

Thumbnail

Pharmacoeconomic analyses

Event: HFA Clinical Trials in Heart Failure Course

Topic: Heart Failure

Session type: Symposium

Thumbnail

Closure of the day

Event: HFA Clinical Trials in Heart Failure Course

Topic: Heart Failure

Session type: Special Event

Thumbnail

Welcome from the HFA Leadership and Course Organisers

Event: HFA Clinical Trials in Heart Failure Course

Topic: Heart Failure

Session type: Special Event

Thumbnail

Closure of the day

Event: HFA Clinical Trials in Heart Failure Course

Topic: Heart Failure

Session type: Special Event

Thumbnail

Keynote lectures

Event: HFA Clinical Trials in Heart Failure Course

Topic: Heart Failure

Session type: Symposium

Thumbnail

The new era of SGLT2 Inhibitors in Cardiovascular Disease: beyond glucose control

Event: EuroCVP 2023 – The annual meeting on advances in cardiovascular pharmacotherapy

Topic: Cardiovascular Pharmacotherapy

Session type: Teaching Course

Thumbnail

Factors detemining prognosis biomakers to scores

Event: Heart Failure 2023

Topic: Chronic Heart Failure

Session type: Rapid Fire Abstracts

Thumbnail

Addressing gender differences and ethnic disparities in heart failure

Event: Heart Failure 2023

Topic: Research Methodology

Session type: Rapid Fire Abstracts

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb